Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Gynecol Oncol. 2011 Sep 26;123(3):461–466. doi: 10.1016/j.ygyno.2011.08.030

Table 2.

Additional Surgical Procedures and Surgical Complications by Treatment Group*

Primary Debulking Surgery (PDS)
n (%)
Interval Debulking Surgery (IDS)#
n(%)
p value

No. of patients 4,827 577

Any Bowel Resection/Ostomy 1442 (29.88) 95 (16.46) <0.001
 Small Bowel Resection 309 (6.40) 22 (3.81) 0.014
 Large Bowel Resection 992 (20.56) 64 (11.09) <0.001
 Ostomy 928 (19.23) 45 (7.80) <0.001
 Rectal Resection 250 (5.18) 22 (3.81) 0.156
Any Upper Abdominal Procedure 194 (4.02) 17 (2.95) 0.208
Length of Stay Mean Days (SD) 11.53 (10.27) 7.89 (7.17) <0.001
ICU Stay 2049 (42.71) 160 (28.22) <0.001
Transfusion during surgical stay 329 (6.86) 31 (5.47) 0.211
Surgical Injury 316 (6.55) 31 (6.42) 0.276

30-Day Complications
 Cardiac 556 (11.52) 53 (9.19) 0.094
 Thromboembolic Event 229 (4.75) 28 (4.85) 0.909
 General Infections 854 (17.70) 66 (11.44) <0.001
 Gastrointestinal 1701 (35.25) 168 (29.12) 0.003
 Neurological or Renal¥ 208 (4.25) 13 (2.25) 0.021
 Reoperation 479 (9.93) 49 (8.49) 0.273
 Pulmonary 542 (11.23) 22 (3.81) <0.001
 Wound Infection/Breakdown 997 (20.66) 82 (14.21) 0.001
*

Surgical stay refers to the hospitalization at the time of either primary debulking surgery or interval debulking surgery following neoadjuvant chemotherapy, inpatient claims data for this hospitalization was missing for 41 patients. p values are using Chi2 or t-test comparing PDS to IDS

#

includes only women who had surgery following neoadjuvant chemotherapy.

¥

combined categories for patient confidentiality due to low numbers.